Medicare Revisits Power-Wheelchair Codes; ECRI Wants More iBOT Studies
This article was originally published in The Gray Sheet
Executive Summary
ECRI recommends larger, longer-term studies of Johnson & Johnson/Independence Technology's iBOT 3000 stair-climbing power wheelchair to better determine the device's cost-to-benefit ratio